Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...
Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...
Officials say the risk is generally low but urged Americans to take precautions while health experts closely monitor the ...
Louisiana has reported the first U.S. fatality from avian influenza. Most of the country’s human cases have been mild ...
The first human death from bird flu in the United States has intensified calls for the government to ramp up efforts to stave ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
Key Takeaways The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and ...
Infectious disease specialist, Dr. Peter Chin-Hong discusses the first human bird flu death in the country, what is causing ...
The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus could mutate and become more transmissible.
Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK ...
Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading ...
The Louisiana Department of Health announced Jan. 6 that a patient hospitalized last month for H5N1 bird flu has died, ...